Actovegin® (5 ml) Deproteinized calf blood hemodic

Patients with diseases of the peripheral and central nervous systems are treated with antioxidants, antiplatelet agents and vasoactive drugs. Doctors can prescribe Actovegin tablets during hypoxia, edema, trauma, which cause a lack of oxygen in the cells. Familiarize yourself with the release form, composition, indications for use, mechanism of action, and drug analogues.

Actovegin - from what helps

Actovegin has a complex effect on nerve cells. The drug is often used in the treatment of diseases that are associated with the nervous system. The medicine has such properties:

  • increases glucose uptake
  • improves oxygen absorption by tissues
  • stimulates metabolism (cell metabolism),
  • promotes oxygen utilization, glucose transport to the body tissues.

Each person has limiters of normal energy metabolism functions (tissues are not supplied with oxygen, oxygen absorption is disturbed, hypoxia occurs), and vice versa, increasing energy consumption (tissue regeneration). The drug helps to improve the absorption of substances by the body, has a positive effect on the blood supply system. Especially effective remedy for circulatory disorders.

Dosage Form

Solution for injection 40 mg / ml - 2 ml, 5 ml

active substance - deproteinized hemoderivat blood of calves (in terms of dry substance) * 40.0 mg.

Excipients: water for injections

* contains about 26.8 mg of sodium chloride

Transparent, yellowish solution.

Pharmacodynamics and pharmacokinetics

Actovegin is an antihypoxant. It is obtained by the use of dialysis and ultrafiltration. The drug has a good effect on the transportation and utilization of glucose, stabilizes the plasma membrane of cells during ischemia through oxygen consumption. The tool begins to act after half an hour after ingestion. The maximum effect can be observed after 3 hours.

Pharmacokinetics has not been studied deeply, but all the components of the drug are present in the body in its natural form. A decrease in the pharmacological effect of the drug was not found in people with hepatic or renal insufficiency, changes in the metabolism associated with older age. The effect on newborns is not fully understood, especially considering the peculiarities of their metabolism, therefore it is recommended to use it with caution and only as prescribed by the attending physician.

Actovegin - indications for use

Due to the infusion of the drug, the concentration of hemoglobin, DNA and hydroxyproline increases. According to the instructions annotation, these tablets are used only as an auxiliary drug for:

  • ischemic and hemorrhagic strokes,
  • head injuries and encephalopathy,
  • violations of arterial circulation,
  • disorders of the venous circulation.

In case of diabetes, the remedy reduces pain or burning in the lower extremities, is used for burns, except for the 4th degree, for healing wounds and other skin lesions. In addition, the tool helps to improve:

  • metabolism,
  • venous blood supply to the brain,
  • peripheral circulation.

Pharmacological properties


It is impossible to study the pharmacokinetic characteristics (absorption, distribution, elimination) of Actovegin®, since it consists only of the physiological components that are usually present in the body.

Actovegin® has an antihypoxic effect, which begins to manifest itself no later than 30 minutes after parenteral administration and reaches a maximum on average after 3 hours (2-6 hours).


Actovegin® antihypoxant. Actovegin® is hemoderivate, which is obtained by dialysis and ultrafiltration (compounds with a molecular weight of less than 5,000 daltons pass). Actovegin® causes organ-independent intensification of energy metabolism in the cell. Actovegin® activity is confirmed by measuring increased absorption and increased utilization of glucose and oxygen. These two effects are interrelated, and they lead to an increase in the production of ATP, thereby providing a greater degree of energy needs of the cell. Under conditions that limit the normal functions of energy metabolism (hypoxia, lack of substrate), and with increased energy consumption (healing, regeneration) Actovegin® stimulates the energy processes of functional metabolism and anabolism. The secondary effect is increased blood supply.

The effect of Actovegin® on the absorption and utilization of oxygen, as well as insulin-like activity with stimulation of glucose transport and oxidation, are important in the treatment of diabetic polyneuropathy (DPN).

In patients with diabetes mellitus and diabetic polyneuropathy Actovegin® reliably reduces the symptoms of polyneuropathy (stabbing pain, burning sensation, parasthesia, numbness in the lower limbs). Disorders of sensitivity are objectively reduced, the patients' mental state improves.

Dosage and administration

Actovegin®, solution for injection, is used intramuscularly, intravenously (including in the form of infusions) or intraarterially.

Instructions for the use of ampoules with one break point:

Take the vial so that the top containing the label is at the top. Gently tapping the finger and shaking the ampoule, allow the solution to flow down from the tip of the ampoule. Break off the top of the ampoule by pressing on the label.

a) Usually recommended dose:

Depending on the severity of the clinical picture, the initial dose is 10-20 ml intravenously or intraarterially, further in 5 ml iv / or slowly intramuscularly daily or several times a week.

When used as an infusion, 10-50 ml are diluted in 200-300 ml of isotonic sodium chloride solution or 5% dextrose solution (basic solution), the speed of administration is about 2 ml / min.

b) Doses depending on indications:

Metabolic and vascular disorders of the brain: from 5 to 25 ml (200-1000 mg per day) intravenously daily for two weeks, followed by a switch to a tablet form of administration.

Disorders of cerebral circulation and nutrition, such as ischemic stroke: 20-50 ml (800-2000 mg) in 200-300 ml of 0.9% sodium chloride solution or 5% glucose solution, intravenously drip daily for 1 week, then 10-20 ml (400-800 mg) intravenously drip - 2 weeks with the subsequent transition to the tablet form of admission.

Peripheral (arterial and venous) vascular disorders and their consequences: 20-30 ml (800-1000 mg) of the drug in 200 ml of 0.9% sodium chloride solution or 5% glucose solution, intraarterially or intravenously daily, the duration of treatment is 4 weeks.

Diabetic polyneuropathy: 50 ml (2000 mg) per day intravenously for 3 weeks with the subsequent transfer to the tablet form of administration - 2-3 tablets 3 times a day for at least 4-5 months.

Venous ulcers of the lower extremities: 10 ml (400 mg) intravenously or 5 ml intramuscularly daily or 3-4 times a week depending on the healing process

The duration of treatment is determined individually according to the symptoms and severity of the disease.

Special instructions

Intramuscularly it is desirable to introduce slowly no more than 5 ml, since the solution is hypertonic.

In view of the possible occurrence of anaphylactic reactions, it is recommended that prior to the initiation of therapy a test injection (2 ml intramuscularly).

The use of Actovegin® should be carried out under medical supervision, with adequate facilities for the treatment of allergic reactions.

For infusion, Actovegin®, solution for injection, can be added to an isotonic solution of sodium chloride or 5% glucose solution. Aseptic conditions must be met, since Actovegin® for injection contains no preservatives.

From a microbiological point of view, open ampoules and prepared solutions should be used immediately. Solutions that have not been used must be disposed of.

As for mixing Actovegin® solution with other solutions for injection or infusion, physical and chemical incompatibility, as well as the interaction between active substances cannot be excluded, even if the solution remains optically transparent. For this reason, Actovegin® solution should not be administered in a mixture with other drugs, except those mentioned in the instructions.

The injection solution has a yellowish tint, the intensity of which depends on the batch number and the starting material, but the color of the solution does not affect the efficacy and tolerability of the drug.

Do not use an opaque solution or a solution containing particles!

Use with caution when hyperchloremia, hypernatraemia.

There is currently no data available and usage is not recommended.

Use during pregnancy

Use of the drug Actovegin® is allowed if the expected therapeutic benefit exceeds the possible risk to the fetus.

Use during lactation

When using the drug in the human body, there were no negative effects on the mother or child. Actovegin® should be used during lactation only if the expected therapeutic benefit exceeds the potential risk to the child.

Features of the effect of the drug on the ability to drive a vehicle or potentially dangerous machinery

No or minor effects are possible.


There is no data on the possibility of an overdose with Actovegin®. Based on pharmacological data, no additional undesirable effects are expected.

Release formand packing

Solution for injection 40 mg / ml.

On 2 and 5 ml of a preparation in colorless glass ampoules (type I, With a break point. On 5 ampoules in plastic blister strip packaging. On 1 or 5 blister strip packagings with the instruction for application are placed in a cardboard pack. Transparent protective round stickers with holographic inscriptions and control of the first opening are glued onto the pack.

For ampoules with a volume of 2 ml and 5 ml, the marking is applied on the surface of the glass of the ampoule or on the label glued to the ampoule.

Registration Certificate Holder

Takeda Pharmaceuticals Ltd., Russia

Packer and quality control issuer

Takeda Pharmaceuticals Ltd., Russia

Address of the organization that receives claims from consumers on the quality of products (goods) in the Republic of Kazakhstan:

Representation of Takeda Osteuropa Holding GmbH (Austria) in Kazakhstan

Release form and composition

The active component of the drug is deproteinized calf-blood hemoderivate at a dosage of 40 mg per milliliter of solution. The injection form of Actovegin is produced in ampoules of different volume and dosage:

  • 400 mg solution, in a package of 5 ampoules of 10 ml each,
  • 200 mg solution, in a package of 5 ampoules of 5 ml each,
  • solution of 80 mg, in a package of 25 ampoules of 2 ml.

Ampoules are in a plastic container. Secondary packaging is made of cardboard. It contains information about the production series and the expiration date. Inside the carton, in addition to the container with ampoules, is also a detailed instruction. The color of the solution is yellowish with various shades depending on the series of release. The color intensity does not affect the sensitivity to the drug and its effectiveness.

Indications for use

Actovegin can be prescribed for many painful conditions. Its use is justified in such diseases:

  • therapy of hemorrhagic stroke and residual effects after it,
  • encephalopathy, having a different origin,
  • failures observed in the work of venous, peripheral or arterial blood,
  • ischemic stroke,
  • various craniocerebral injuries,
  • angiopathy, especially of diabetic origin,
  • radiation, thermal, solar, chemical burns up to 3 degrees,
  • diabetic peripheral polyneuropathy,
  • trophic damage,
  • wounds of various origins that are difficult to treat,
  • ulcerative skin lesions,
  • occurring bedsores,
  • lesions on the mucous membranes and skin, triggered by radiation damage,
  • radiation neuropathy.

Dosing and Administration

For the intravenous route of administration, Actovegin may be administered by drip or stream. Before the introduction of a vein, you need to dissolve the drug in a solution of sodium chloride 0.9% physiological or 5% glucose solution. The permitted final dose of Actovegin is up to 2000 mg of dry matter per 250 ml of solution.

For intraarterial administration, Actovegin should be used in a dosage of 5 to 20 ml per day.

The dose for intramuscular injection may not exceed 5 ml per 24 hours. In this case, the introduction is slow.

After assessing the patient's condition, the required dose is selected. The recommended dosage at the beginning of therapy is 5 - 10 ml i.p. or v / v. In the following days, intravenously in 5 ml or intramuscularly daily or several times over a 7 day period. Intramuscular injections are performed slowly.

In case of a severe condition of the patient, the prescription of Actovegin is recommended intravenously in the drip method at a dose of 20 to 50 ml per day for several days until the condition improves.

In cases of exacerbations of various chronic conditions and in diseases characterized by moderate severity, Actovegin should be administered intramuscularly or intravenously in a 5–20 ml course from 14 to 17 days. Selection of dosage is carried out only by a doctor!

If necessary, a planned course of therapy can be administered at a dosage of 2 to 5 ml per 24 hours by the route of administration to a muscle or vein in a course of 4 to 6 weeks.

The multiplicity of the introduction should be from 1 to 3 times. This amount varies depending on the initial condition of the patient.

When treating patients with diabetic polyneuropathy, it is better to begin the use of Actovegin with intravenous administration. The dosage in this case is 2 g per day, the course of treatment is 21 days. In the future, it is desirable to switch to a tablet form with a daily dose of 2 to 3 tablets for 24 hours. The course of taking in this way is about 4 months.

Side effects

According to numerous studies, Actovegin injections are well tolerated by patients. Rarely, anaphylactic reactions, allergic manifestations, and anaphylactic shock can occur. Sometimes such side effects may appear:

  • soreness at the injection site or redness of the skin,
  • pain in the head. Sometimes they can be accompanied by a feeling of dizziness, general weakness in the body, the appearance of a shiver,
  • loss of consciousness,
  • dyspeptic manifestations: vomiting, diarrhea, abdominal pain, nausea,
  • tachycardia,
  • sudden blanching of the skin,
  • rash on the body (urticaria), itchy skin, flushing, angioedema,
  • joint pain or muscle pain
  • acrocyanosis
  • a decrease or, conversely, an increase in blood pressure,
  • pain in the lumbar region,
  • paresthesias,
  • excited state
  • suffocation,
  • breathing problems
  • difficulty in swallowing,
  • sore throat,
  • feeling of pressure in the chest,
  • heartache,
  • temperature increase,
  • intensifying the process of sweating.

Actovegin tablets - instructions for use

Actovegin is taken orally. During the day, the patient should drink three times 1-2 tablets.They do not need to chew, you can drink water or juice (any liquid). It is recommended to use the drug before meals. The course of treatment is 30-45 days. Patients with diabetic polyneuropathy are prescribed orally 2-3 tablets 3 times / day. The course of medication is 4-5 months. The duration of the reception is determined by the neurologist.

Terms of sale and storage

The drug Actovegin can be bought only by prescription of the attending physician. Keep the medicine out of the reach of children and protected from light. The temperature in the room should not exceed 25 degrees. The tool has a shelf life of 3 years.

The drug has a number of analogues. However, not all of them have the same effect on the body, and their composition does not always correspond to the amino acids present in the human body. From the presented analogues there are no drugs that can be applied to the child. The list includes Curantil, Dipyridamole and Vero-Trimetazidine:

  • Curantil is indicated for thrombosis, prevention and treatment of cerebral circulation, prevention of placental insufficiency, myocardial hypertrophy. Contraindicated if diagnosed: acute myocardial infarction, angina pectoris, severe arrhythmia, gastric ulcer, liver failure.
  • Dipyridamole is used to prevent postoperative thrombosis, myocardial infarction, cerebrovascular accident, and metabolic disorders. Contraindications: acute strokes, atherosclerosis of the coronary arteries, collapse.
  • Vero-Trimetazidine is used for angina. Contraindications: pregnancy, individual intolerance to the components of the drug.

The price of tablets Actovegin

Analogue Actovegin or the drug itself can be purchased at a pharmacy or online store. Specify its price, and then order with delivery in Moscow or Moscow region. You can save the budget due to the monitoring of drug prices in the selected region. Below is a table of the cost of drugs in different online pharmacies:

Christina, 28 years old My mother suffers from venous insufficiency. To improve blood circulation, I bought Actovegin. According to the doctor, when taking the drug, blood is transported faster, tissue regeneration processes are improved. Mom was pleased, returned to the same active life. I recommend to everyone.

Phillip, 43 years old I am a doctor with fifteen years of experience. To improve the well-being of patients who suffer from diseases of the brain, I recommend Actovegin. This drug accelerates the utilization of oxygen, contributes to the speedy recovery of the patient. According to reviews of patients, the drug acts quickly.

Alevtina, 29 years old My father was diagnosed with stroke and glaucoma. Since then, he's lying. For healing of bedsores we began to use Actovegin. By feedback and results we can say that the drug is valid. Doctors speak positively of this medication, as it helps stimulate the utilization of oxygen by cells. Price pleased.

Actovegin injection Price

Actovegin injection for 2 ml, 5 ampoules - 530-570 rubles.

Actovegin injection for 2 ml, 10 ampoules - 750-850 rubles.

Actovegin injection 5ml, 5 ampoules - 530-650 rubles.

Actovegin injection 5ml, 10 ampoules - 1050-1250 rubles.

Actovegin 10ml injection solution, 5 ampoules - 1040-1200 rubles.